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Abstract
The purpose of the current study was to assess social interaction (SI) following acute and repeated 
methamphetamine (MA) administration.
Rats were injected with 5.0 mg/kg of MA and SI was tested 30 minutes or 24 hours later. In 
another group of animals, MA sensitization was induced using 5.0 mg/kg of MA, and SI was 
assessed after one day or thirty days of abstinence.
SI was reduced in rats injected with MA 30 minutes, but not 24 hours, prior to testing, compared 
with saline controls. Impaired SI was observed in combination with active avoidance of the 
conspecific animal. Repeated injections of MA progressively reduced locomotor activity and 
increased stereotypy, indicating that animals were sensitized. However, no differences in SI were 
observed 24 hours or 30 days following the induction of sensitization.
The absence of detectable differences in SI following MA sensitization may be attributable to the 
relatively short regimen used to induce sensitization. However, the current series of experiments 
provides evidence that an acute injection of MA decreases SI and simultaneously increases 
avoidance behavior, which supports a link between psychostimulant use and impaired social 
functioning. These data suggest that the acute injection model may provide a useful model to 
explore the neural basis of impaired social functioning and antisocial behavior.
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Introduction
Methamphetamine (MA) is a widely abused and addictive psychostimulant. Psychostimulant 
abuse can elicit antisocial behaviors such as aggression, violence, and in some cases, 
complete withdrawal from social situations (Homer et al., 2008; Miczek and Tidey, 1989). 
Psychostimulant-induced changes in SI model behavioral impairments observed in several 
psychological disorders (Tordjman et al., 2007), including autism (Scheeren et al., 2012), 
depression (Steger and Kashdan, 2009), as well as anxiety and phobias (Brown et al. 1997). 
More specifically, a parametric assessment of how SI is altered following MA use is 
necessary to identify which behavioral measures are altered as drug use transitions from 
recreational to habitual use. Towards this goal, the current study examined the time course 
of impairments in SI following acute and repeated MA administration.
Individuals who chronically abuse MA exhibit cognitive and behavioral alterations, such as 
increased anxiety (Rawson, 2013) and altered executive function, including impaired 
decision-making (Paulus et al., 2003) and attentional deficits (Salo et al., 2009). Similarly, 
rodents exposed to repeated MA show impairments in cognitive flexibility (Kosheleff et al., 
2012), in addition to impaired temporal and episodic memory (Janetsian et al., 2015; 
Belcher et al., 2006). Some deficits in cognition induced by MA use persist after abstinence 
(Salo and Fassbender 2011; Salo et al. 2009; Janetsian et al. 2015), and may increase the 
probability of relapse (Tapert et al., 2004; Reichel et al., 2011). However, it is not known if 
SI is altered after acute or repeated MA use.
Impairments in social functioning are greater in individuals who have high levels of anxiety 
(i.e. general anxiety disorder) (Henning et al., 2007), which suggests that there may be a link 
between the two behaviors. Various clinical disorders and animal models also point to a 
relationship between the two behaviors (for review see Allsop et al. 2014). Animal models 
also support a role between social functioning and anxiety-like behavior during a SI task 
(File and Seth, 2003; Lungwitz et al., 2014). Assessment of SI and anxiety-like behaviors in 
rodent models facilitates the exploration of the neural systems that mediate each behavior 
and how they might be altered in neuropsychiatric disorders such as addiction. Furthermore, 
this link between social functioning and anxiety in both humans and animal models suggest 
a common neural substrate for both behaviors (Allsop et al., 2014).
In addicted individuals, the most common pattern of MA use is using between 1–6 times a 
day (Homer et al., 2008). Since this pattern is most common in humans, repeated 
intermittent MA use, such as the regimen used in these experiments, might precede the 
transition to the stage of addiction where drug use is florid. This makes examination of both 
repeated and single use very important in order to understand the time course in which 
cognitive and behavioral changes may occur. Animal models provide a powerful and highly 
controlled tool to assess the specific behavioral changes that are associated with each stage 
of addiction, which may not be accessible in clinical populations. For example, one can 
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separate the changes in behavior and neural function that are observed after a single use 
versus those that require repeated administration. Towards this goal, behavioral sensitization 
protocols are particularly useful. Sensitization is defined as an augmented psychomotor 
response with repeated administration of a pharmacological agent (Pierce and Kalivas, 
1997) and is paralleled by a number of protracted changes in neurobiology and physiology 
(Lapish et al., 2012; Lodge and Grace, 2008; Bastia et al., 2005; Janetsian et al., 2015). 
Importantly, a number of the behavioral and cognitive abnormalities found in addicted 
individuals are also observed in sensitized animals, thus lending translational validity to this 
model (Fletcher et al., 2007). Therefore, this study used sensitization as a method to contrast 
the behavioral effects evoked by acute MA compared with those following repeated MA 
administration.
The primary goal of the current study was to assess the persistent effects of MA on SI. 
Towards this goal, SI was first examined in a group of animals either 30 minutes or 24 h 
after a single injection of MA. MA has been previously shown to impair SI 30 minutes after 
injection (Slamberova et al., 2010, 2011) and thus provides an important control condition 
indicating that deficits are observable with the experimental methods used here. Secondly, a 
behavioral sensitization protocol that was previously shown to induce persistent deficits in 
recognition memory (Janetsian et al., 2015) was used to examine the persistent effects of 
repeated MA on SI. Currently there are no published studies on the effects of repeated MA 
on SI after abstinence. This missing aspect of the literature is particularly salient as a 
repeated pattern of MA use is common amongst those who abuse MA (Homer et al., 2008). 
Therefore there is a critical and unmet need to investigate the consequences of repeated MA 
administration on SI after abstinence.
Methods
Subjects
Adult male Sprague-Dawley rats (n = 96) (Harlan, Indianapolis, IN) that weighed 250–300g 
were individually housed and maintained on a reverse light/dark schedule, with lights on 
from 20:00 – 08:00 h (light phase) and lights off from 08:00 – 20:00 h (dark phase). The 
experiments were tested in the dark phase of the light/dark cycle under the same lighting 
conditions as in the colony room. All animals had free access to food and water and were 
handled for 10 minutes a day for one week prior to experimentation. Each experiment was 
conducted in a separate group of animals. All procedures were approved by the Purdue 
School of Science Animal Care and Use Committee and conformed to the Guidelines for the 
Care and Use of Mammals in Neuroscience and Behavioral Research (National Academic 
Press, 2003).
Locomotor Activity and Stereotypy
Locomotor activity and stereotypy were recorded in ANY-maze (Wood Dale, IL) and 
acquired with a video camera mounted above the locomotor chamber. For locomotor 
activity, distance travelled (m) was recorded and included all horizontal movement, whether 
it was during SI or social avoidance. For stereotypy, behavior was scored manually by an 
observed blind to experimental conditions (Ellinwood and Balster, 1974).
Janetsian et al. Page 3
Behav Pharmacol. Author manuscript; available in PMC 2016 December 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Social Interaction
All animals were individually habituated in an open field chamber (86.36 × 93.98 × 31.24 
cm) for 10 minutes for two consecutive days. The chamber was illuminated with a red light. 
Conspecific partner rats that were age, gender, and weight matched were used in no more 
than three test sessions. In line with other labs that use the SI task (e.g. Lungwitz et al., 
2014) the partner rat was used more than once in this set of experiments and sessions were 
separated by at least 30 minutes. Partner rats were handled one-week prior to 
experimentation and individually habituated under the exact same procedures as the 
experimental animals. On the testing day, one partner rat was placed in the open field 
chamber (with no exposure to drug) followed by the experimental rat. The two rats were left 
in the chamber for 5 minutes and activity was recorded using ANY-maze via a video camera 
mounted above the chamber. Animals were then placed back into their home cages. Each 
video was manually scored for interaction, by an observer blind to the conditions, using the 
methods of Truitt et al. (2007). Interaction was considered as sniffing of and physical 
contact (e.g. crawling on or grooming) with the partner rat. All SI experiments took place in 
the same open field to eliminate the possibility of contextual differences.
Avoidance Behavior
Avoidance was assessed as a second behavioral measure to characterize whether the acute 
effect of MA was associated with an overall decrease in movement (causing decreases in 
both SI and avoidance) or whether it was specific to one behavior. Avoidance was measured 
in the first two experiments during the 5 minute SI test, and scored by an observer blind to 
the experimental conditions. Avoidance consisted of the experimental rat avoiding contact 
with the partner rat by moving away when the partner rat sniffed or initiated physical contact 
with the experimental rat. A ratio of this behavior was made using the following data: total 
time experimental rat avoided contact/total time partner rat initiated and continued making 
contact with experimental rat (referred to as 'social avoidance (%)' in the figures). More 
specifically, avoidance behavior consisted of measuring the time when the experimental rat 
moved away from the conspecific rat following the initiation of contact via sniffing or 
physical contact by the conspecific. Avoidance was quantified from the moment the 
experimental animal turned away from the conspecific animal. As long as the experimental 
rat was actively moving away from the conspecific rat, this was considered avoidance.
Experiments
The timeline of experiments and numbers of experimental animals per experiment are 
summarized in Fig. 1.
Experiment 1: The effects of acute MA on SI—To assess the acute 'on-board' effects 
of MA on SI, rats were first individually habituated for two consecutive days in the SI 
chamber as described above and no MA was administered. On the testing day, experimental 
rats received a single injection of MA (n=7) or SAL (n=8). Thirty-minutes after the 
injection, SI, avoidance behavior, locomotor activity, and stereotypy were assessed in the SI 
chamber for 5 minutes (i.e. 30–35 min post-injection). In total, six rats were used as partner 
animals.
Janetsian et al. Page 4
Behav Pharmacol. Author manuscript; available in PMC 2016 December 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Experiment 2: The effects of a single exposure of MA on SI following short-
term (24h) abstinence—Experiment 2 was conducted to assess whether a single injection 
of MA had a residual effect on SI the following day (24 hours following a single MA 
injection). Rats were first habituated for two days in the SI chamber as in experiment 1. 
One-hour following the second SI habituation on day 2, rats were placed in the locomotor 
chamber for 60 min, removed briefly for administration of MA (n=8) or SAL (n=8), and 
then placed back into the locomotor chamber for an additional 60 min to assess locomotor 
activity and stereotypy. On the third day, locomotor activity, stereotypy, SI and avoidance 
behavior were assessed in the SI chamber as in experiment 1. Six partner rats were used in 
this experiment, which were different from the rats used previously.
Experiment 3: The effects of repeated MA on SI following short-term (24h) 
abstinence—Animals received repeated injections of MA or SAL (MA: n=10, SAL: n=9). 
Before injections, animals were acclimated for 60 min to locomotor chambers (54.61-cm 
diameter × 41.91-cm height). Then, animals were injected with a single injection of 5.0 
mg/kg of MA (SENS) or SAL (CTRL) and placed back into the chamber for another 60 min. 
Animals received a single injection every other day for 13 days (one injection on Day 1, 3, 
5, 7, 9, 11, and 13: 7 total injections; induction phase). On days that rats did not receive an 
injection (Days 2, 4, 6, 8, 10, and 12), they were left undisturbed in their home cages. 
Following Day 13, rats were then left undisturbed for one week in their home cage (Days 
14–20). An identical treatment was administered on the 'Sensitization Test' (Day 21) as 
during the induction phase (i.e. SENS rats received an injection of 5.0 mg/kg of MA and 
CTRL rats received an injection of SAL). To assess sensitization, distance travelled (m) and 
stereotypy (Ellinwood and Balster, 1974) were the dependent variables. Following the last 
injection on Day 21, all rats were then habituated to SI chambers for two days then tested for 
SI with a partner rat on the third day to evaluate the consequences of repeated MA 
administration on SI following short-term abstinence. Seven novel partner rats were used in 
this experiment.
Experiment 4: The effects of repeated MA on SI following extended (30 day) 
abstinence—In Experiment 4, a separate group of animals went through the same 
sensitization induction regimen as in experiment 3 (MA: n=10, SAL: n=10). However, after 
the final MA injection (Day 21), animals were left in their home cages for thirty days and 
then assessed on SI after 30 days of abstinence. Seven novel partner rats were used in 
experiment 4.
Drug Treatments
On injection days, rats were administered either 0.9% saline (SAL) or Methamphetamine 
Hydrochloride (MA; Sigma Chemical Co., St Louis, Mo., USA) via i.p. injection. MA was 
injected at a dose of 5.0 mg/kg in a final volume of 1.0 ml/kg after being dissolved in sterile 
SAL.
Data Analysis
For experiments 1 and 2, a two-tailed unpaired t-test was used to examine differences in 
locomotor activity between groups injected with SAL or MA. Stereotypy was scored using a 
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1–9 rating scale (Ellinwood and Balster, 1974) and group differences were evaluated via a 
two-tailed Mann-Whitney U-test. For each of experiments 3 and 4, locomotor activity was 
analyzed using repeated-measures analysis of variance (ANOVA) with treatment as a 
between-subjects factor and days as a within-subjects factor. Using separate Kruskal-Wallis 
analyses, stereotypy was analyzed comparing Days 1–8 in SENS animals in the short-term 
abstinence group, CTRL animals in the short-term abstinence group, SENS animals in the 
extended abstinence group, and CTRL animals in the extended abstinence group. Bonferroni 
post-hoc and Mann-Whitney U tests were used for between-subjects testing for locomotor 
activity and stereotypy, respectively. Dunnett's and Dunn's multiple comparisons were used 
for within-group testing locomotor activity and stereotypy, respectively. To assess the 
relationship between locomotor activity and stereotypy in animals injected with repeated 
MA from experiment 3 and 4 (collapsed), a Spearman correlation was conducted. Each 
value consisted of the rat's mean locomotor activity or stereotypy score over 60 min of 
recording for that day (12 total bins).
For experiments 1 and 2, avoidance behavior was assessed between SAL and MA via a two-
tailed unpaired t-test. For all experiments, SI was assessed between SAL and MA using a 
two-tailed unpaired t-test. To further assess if there was an interaction between abstinence 
period and treatment, a two-way ANOVA was used to assess SI data between CTRL and 
SENS from experiments 3 and 4. The between-subject factors were time (one-day or 30-day 
abstinence) and treatment (CTRL or SENS). P-values for Bonferroni, Dunnett's, and Dunn's 
tests are reported as already corrected for number of comparisons by this statistic. 
Significance thresholds for Mann-Whitney U tests (alpha) were adjusted for the number of 
comparisons and are stated in the results. Unless otherwise stated, p < 0.05 was used for all 
statistical analyses.
Results
Experiment 1: The effects of acute MA on SI
Analysis of locomotor activity revealed significantly lower locomotor activity in animals 
injected with 5.0 mg/kg MA compared to animals injected with SAL (t(13) = 5.49, p < 
0.001) during the 30–35 minute time period following injection (Fig. 2A). Furthermore, 
animals injected with MA had higher stereotypy scores compared to animals injected with 
SAL (Mann-Whitney U = 6.00, p < 0.01, Fig. 2B). Animals injected with MA interacted 
with partner rats significantly less than animals injected with SAL (unpaired t-test, t(13) = 
7.37, p < 0.001; Fig. 2C). To further investigate these effects, and because it was possible 
that reductions in locomotor activity and increased stereotypy could interfere with 
measurements of SI, the time spent by the experimental rat actively avoiding the partner rat 
was quantified (see methods). Animals injected with MA spent significantly more time 
avoiding partner-initiated interactions compared to animals injected with SAL (unpaired t-
test, t(13) = 2.66, p < 0.05, Fig. 2D).
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Experiment 2: The effects of a single exposure of MA on SI following short-term (24hr) 
abstinence
Increased locomotor activity was observed in response to a single injection of 5.0 mg/kg 
MA 24 h prior to SI testing (unpaired t-test, t(14) = 2.91, p < 0.05; Fig. 3A). Furthermore, 
animals injected with MA were hyperactive, as indicated by a score between 5 and 6 on the 
stereotypy scale, and they had significantly higher scores than animals injected with SAL 
(Mann-Whitney U = 0.0, p < 0.001; Fig. 3B). During SI, there were no significant 
differences between the two groups in locomotor activity (unpaired t-test, t(10) = 0.17, NS, 
Fig. 3C) or stereotypy scores (Mann-Whitney U = 24.50, NS; Fig. 3D) in the SI chamber. 
Furthermore, there was no significant difference between SAL and MA groups in total time 
interacting during SI (unpaired t-test, t(14) = 0.76, NS; Fig. 3E) or in avoidance time 
(unpaired t-test, t(14) = 0.30, NS, Fig. 3F), suggesting that there were not residual effects on 
behavior 24 h after a single MA injection.
Experiments 3 & 4: The effects of repeated MA on SI following short term (one-day) and 
extended (30-day) abstinence
Locomotor activity and stereotypy throughout the injection regimen in animals that received 
repeated MA or SAL from experiments 3 and 4 is shown in Fig. 4. It is apparent that these 
two behaviors are inversely related in the SENS group, which became more evident as the 
injection regimen progressed. When examining the relationship between locomotor activity 
and stereotypy in SENS animals (Days 1–21), there was an initial nonsignificant negative 
relationship between locomotor activity and stereotypy on Days 1–9 that reached 
significance on Days 11–21 (Table 1).
Analysis of locomotor activity from animals in the short-term abstinence group (experiment 
3; Days 1–21) revealed an initial increase in the SENS group, indicated by significant main 
effects of time (F(7,119) = 4.32, p < 0.001) and treatment (F(1,17) = 54.27, p < 0.001), and a 
significant time by treatment interaction (F(7,119) = 4.36, p < 0.001) (Fig. 5A). When 
examining within-group differences, Dunnett's multiple comparison indicated that SENS 
animals had significantly decreased locomotor activity on Days 11 & 13 when compared to 
Day 1 in the short-term abstinence group. The same pattern followed for animals in the 
extended abstinence group (experiment 4: time: F(7,126) = 4.96, p < 0.001; treatment: 
F(1,18) = 22.34, p < 0.001; time by treatment interaction F(7,126) = 3.01, p < 0.01; Fig. 
6A). Furthermore, higher locomotor activity was observed in the SENS group compared to 
the CTRL in both experiments (Figs. 5A & 6A). Lastly, in both experiments, when SENS 
animals were injected and tested for the 8th time on Day 21, to confirm sensitization, they 
had significantly decreased locomotor activity compared to Day 1 (Fig,. 5A & Fig,. 6A).
When examining stereotypy on Days 1–21 in animals from experiment 3, an increase in 
stereotypy was observed in the SENS group only (Kruskal-Wallis, χ2 = 44.71, p < 0.001; 
Fig. 5B). To assess between-group differences, Mann-Whitney U tests were adjusted to α = 
0.00625 for multiple comparisons and a significant difference in stereotypy score between 
CTRL and SENS groups was observed on all days (Fig. 5B). Lastly, Dunn's multiple 
comparison revealed that SENS animals had significantly higher stereotypy scores on Days 
1–21 compared to Day 1 (Fig. 5B). Similar results were obtained when assessing stereotypy 
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in experiment 4 (Kruskal-Wallis, χ2 = 28.82, p < 0.001; Fig. 6B). Mann-Whitney U tests 
confirmed differences in stereotypy scores between SENS and CTRL groups on all days 
(Fig. 6B). Lastly, Dunn's multiple comparisons revealed increased stereotypy scores on 
Days 13 & 21 when compared to Day 1 in the SENS group (Fig. 6B).
There were no significant differences between CTRL and SENS animals in total time 
interacting after 24 h (unpaired t-test, t(17) = 0.55, NS; Fig. 5C) or 30 days (unpaired t-test, 
t(18) = 0.63, NS; Fig. 6C) following the induction of sensitization. There were no 
differences in SI between SENS versus CTRL following one day or 30 days of abstinence 
(Figs. 5C and 6C), as indicated by non-significant main effects of time (F(1,35) = 1.63, 
>NS) and treatment (F(1,35) = 0.68, NS>), and time by treatment interaction (F(1,35) = 
0.04, >NS).
Discussion
To our knowledge, this study is the first to directly compare the effects of acute versus 
repeated, sensitization-inducing regimens, of MA treatment on SI. Our data indicate that SI 
is reduced when MA is 'on-board', but not 24 h after a single injection or after repeated 
injections of MA.
Repeated MA-induced sensitization is characterized by a transition from hyperlocomotion 
to stereotypy
Previous studies show that administering repeated doses of MA induces sensitization in 
rodents, which is typically measured as progressive increases in locomotor activity or 
stereotypy to the same dose of drug (Wang et al. 2012). This phenomenon is reported to last 
as long as a year (Paulson et al., 1991). Furthermore, with repeated treatment, the effect of 
MA shifts from hyperactivity to stereotypy (Kuczenski et al., 2009; Fujiwara et al., 1987), 
especially when using higher doses including 5.0 mg/kg and 10.0 mg/kg (Janetsian et al., 
2015; McGuire et al., 2011).
It is has been suggested that locomotor activity and stereotypy are competing behavioral 
states that are mediated by distinct neural circuits (Joyce and Iversen 1984; Segal and 
Mandell, 1974). Increases in locomotor activity are predominantly due to psychostimulant-
induced neuroadaptations in dopamine (DA) neurotransmission within the mesolimbic DA 
system (Koob and Volkow, 2010). Conversely, it is thought that stereotypic behaviors are 
driven by neural circuits in the basal ganglia that are distinct from those that mediate 
hyperlocomotion (Wolgin, 2012). Specifically, gamma-aminobutyric acid (GABA)-ergic 
inputs from the globus palladus to the thalamus inhibit glutamatergic transmission, causing a 
decrease in thalamo-cortical output and an inhibition of movement, resulting in stereotypy 
(Alexander et al., 1986; Parent and Hazrati, 1995; Wolgin, 2012). In the current study, MA 
administration induced an initial increase in locomotor activity that eventually transitioned 
into an increase in stereotypy as the injection regimen progressed. Importantly, our data 
demonstrate that the injection regimen of repeated MA did induce sensitization. 
Furthermore, the negative correlation between locomotor activity and sensitization (Fig. 4), 
supports the notion that these behaviors are mutually exclusive and possibly the 
manifestation of competing neural circuits.
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MA acutely inhibits SI
A decrease in SI was observed in animals given MA for the first time 30 minutes prior to 
behavioral testing. These results are consistent with previous studies that have focused 
solely on acute treatment and also observed decreases in SI after an injection of 0.5, 1.0, or 
1.5 mg/kg of MA 30 minutes prior to SI testing (Šlamberová et al., 2010, 2011). Following 
acute MA, interpretation of SI can be complicated by changes in locomotor activity and 
stereotypy that are evoked by the drug (Joyce and Iversen 1984; Segal and Mandell, 1974). 
It is possible that the decreases in SI were influenced by the emergence of stereotypies. 
However, an examination of avoidance behavior in animals treated with acute MA showed 
that suppression of locomotor activity and the emergence of stereotypy were not solely 
responsible for the changes in behavior, as animals actively avoided contact with the 
conspecific animal, indicating that they were capable of moving. Furthermore, considering 
differences were observed in SI in animals that were administered MA in this experiment, 
this suggests that the scoring methods used are sensitive enough to detect differences in SI. 
Moreover, our findings fall in line with what has been previously reported with an acute 
dose of MA (Slamberová et al., 2010, 2011).
Decreases in SI when MA was 'on-board' could also be due to the anxiogenic effects that are 
brought about by stimulant drugs (Ettenberg and Geist, 1991). Although the current set of 
experiments did not explicitly measure anxiety, it is has been suggested that a decrease in SI 
accompanied by an increase in locomotor activity is indicative of a state of high anxiety, 
whereas an increase in both locomotor activity and SI is indicative of reduced anxiety (File 
and Seth, 2003). While animals were under the influence of MA, we observed a decrease in 
locomotor activity and a decrease in SI. Had we observed a decrease in SI but an increase in 
locomotor activity, a more compelling case could be made that animals were anxious, 
according to the criteria suggested by File and Seth (2003). However, it is still possible, 
even likely, that the decrease in locomotor activity was driven by the emergence of 
behavioral stereotypies, which does not rule out that animals were anxious at this time point. 
In the current set of experiments, it is possible that animals were avoiding SI because they 
were anxious. Future studies will be necessary to directly assess the effects of MA on 
anxiety and how this, in turn, influences SI.
No differences in SI 24 h after a single MA injection or after repeated MA administration
No differences in locomotor activity, stereotypy, SI, or avoidance behavior were observed 
24 h after a single injection of MA. These data clearly indicate that the effects of this acute 
dose of MA on these behavioral measures occur only when the drug is 'on-board' and persist 
for less than 24 h.
There were also no differences in SI between groups after one or 30 days of abstinence from 
repeated administration of SAL or MA. Interestingly, rats from experiments that received 
single injections of MA interacted less than animals that received repeated injections of MA. 
This difference is possibly attributable to differences in handling across these experiments. 
In experiments 1 and 2, rats were handled for one week, whereas rats in the repeated-
treatment groups were handled for one-week prior to experimentation in addition to 
handling during the repeated-injection phase for two weeks. Although there are no studies 
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assessing the effects of handling on SI, Andrews and File (1993) demonstrated that handling 
can reduce behaviors indicative of anxiety on the elevated plus maze. Therefore, animals in 
experiments 3 and 4 had more handling possibly resulting in more SI compared to animals 
in experiments 1 and 2.
Another factor contributing to differences in SI could be age. It has been previously 
demonstrated that older rats typically exhibit less SI compared to younger rats (Garau et al., 
2000; O'Shea et al., 2006). However, age was taken into consideration and controlled for as 
much as possible, such that for experiments 1, 2, and 3, SI was tested on PD 99 or 100. 
However, SI was assessed on PD 129 in experiment 4. Therefore, age was consistent for the 
first three experiments. Although there is a 30-day age difference between experiments 3 
and 4, it is important to point out that the total interaction time in experiment 3 (on PD 99) 
and experiment 4 (on PD 129) was not different between groups, which suggests that age 
did not have an effect on SI. Given that age was controlled for when testing SI, other factors 
were compromised, such as the amount of time animals were individually housed. Animals 
from experiments 3 and 4 were singly housed for 22 days and 52 days, respectively, longer 
than those in experiments 1 and 2, which may have influenced SI times.
When examining SI, SENS animals had very similar SI scores compared to the CTRL group 
after one day and 30 days of abstinence. This is in contrast to a finding from another lab 
(Clemens et al., 2004) that employed a 'binge' method, which has been shown to cause 
neurotoxicity in animals, and to cause decreases in SI in MA-treated rats 4 weeks after the 
treatment regimen (Cho et al., 2001). In this study, rats were injected with SAL or MA (2.5 
mg/kg or 5.0 mg/kg) every two hours for a total of four injections. Four weeks later, rats 
were assessed on SI while the drug was not 'on-board'. The effect on SI observed in Clemens 
et al. (2004), in contrast to the lack of effect in this current study, suggests that SI 
impairments might differ as a function of the regimen used. If this is the case, then the 
regimen used here was not sufficient in terms of dose or frequency of administration to 
decrease SI. However, in addition to employing a different MA dosing regimen than the 
current study, the study by Clemens et al. (2004) assessed SI using a MA-treated partner rat 
rather than a naive rat with no prior drug treatment, which further complicates direct 
comparisons between the two studies.
Repeated administration of MA using this dosing regimen was not sufficient to induce 
deficits in SI, although it does induce deficits in other behaviors such as temporal and 
recognition memory (Janetsian et al., 2015). MA-induced alterations in behavior may be 
attributable to adaptations in neural circuits that govern them. For example, transient 
inactivation of the prefrontal cortex impairs temporal memory (Hannesson et al., 2004), 
whereas transient inactivation of the hippocampus and perirhinal cortex impair recognition 
memory (Broadbent et al., 2010; Hannesson et al., 2004). However, neural circuits of the 
cerebral cortex, limbic system, and cerebellum are all implicated in the control of social 
behavior (Adolphs, 2002; Bachevalier and Málková, 2006; Baron-Cohen et al., 2000; Truitt 
et al., 2007), which suggests that the neural circuits that support SI are perhaps more 
distributed, or redundant, than those necessary for temporal and recognition memory. If the 
neural circuits that are engaged during SI are indeed distributed and complex, and 
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considering the evolutionary advantage conferred by engaging in social behaviors (Adolphs, 
2001), then it follows that this behavior should be particularly robust to insult.
The current study indicates that a sensitization regimen previously established to impair 
temporal and recognition memory is insufficient to impair SI. This should be considered in 
future studies that seek to examine the effects of MA on SI. Moreover, these data indicate 
that the reductions in SI following acute MA administration are attributable to active 
avoidance of the conspecific animal, which may reflect an anxiogenic state.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. 
A timeline of experiments following (A) acute MA injection while MA is 'on-board' (B) 
single MA injection (C) repeated MA injection after 1 day of abstinence (D) repeated MA 
injection after 30 days of abstinence.
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Fig. 2. 
The effects of MA 30- min after an injection of SAL or 5.0 mg/kg MA. (A) Locomotor 
activity (during the first 5 min of recording). (B) Stereotypy (during the first five minutes of 
recording), with a score of 6 indicating stereotypy (dashed line). (C) SI time. (D) Avoidance 
time, measured as total time the experimental animal avoided contact /total time partner the 
animal initiated and continued making contact with experimental rat. All data are depicted 
as mean ± SEM; *p<0.05, **p<0.01, ***p<0.001. (MA: n = 7; SAL: n = 8; Partners: n = 6)
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Fig. 3. 
The effects of a single exposure of MA on SI following short-term (24-h) abstinence. (A) 
Locomotor activity in the locomotor chamber immediately after a SAL or 5.0 mg/kg MA 
injection. (B) Stereotypy immediately after a SAL or 5.0 mg/kg MA injection, with a score 
of 6 or above indicating stereotypy (dashed line). (C) Locomotor activity in the SI chamber 
24 h post-injection. (D) Stereotypy score in the SI chamber 24 h post-injection. (E) Mean SI 
time (throughout five minutes of SI recording) 24 h after a SAL or 5.0 mg/kg MA injection. 
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(F) Mean avoidance time 24 h after a SAL or 5.0 mg/kg MA injection. All data are depicted 
as mean ± SEM. (MA: n = 8; SAL: n = 8; Partners: n = 6).
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Fig. 4. 
Locomotor activity and stereotypy (shown in 5 min bins for a total of 60 min) in animals 
injected repeatedly with MA (n = 20) or SAL (n = 19) on Days 1–21 (data from experiments 
3 & 4). M. Correlation values for the SENS group can be found in Table 1. All data are 
depicted as mean ± SEM.
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Fig. 5. 
The effects of repeated MA on SI after short-term abstinence. (A) Locomotor activity 
following injections for each day of the induction phase (**p <0.01, ***p <0.001, 
****p<0.0001, significantly higher locomotor activity compared to CTRL 
animals; ###p<0.001, ####p<0.0001, significantly lower within-group locomotor activity 
compared to Day 1 in SENS animals). (B) Stereotypy following injections for each day of 
the induction phase (***p< 0.001, significantly higher stereotypy ratings compared to CTRL 
animals; #p<0.05, ##p<0.01, ###p<0.001, significantly higher within-group stereotypy 
compared to Day 1 in SENS animals). (C) Interaction time one day after the last SAL or 5.0 
mg/kg MA injection. All data are depicted as mean ± SEM. (MA: n = 10; SAL: n = 9; 
Partners: n = 7).
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Fig. 6. 
The effects of repeated MA on SI after extended abstinence. (A) Locomotor activity 
following injections for each day of the induction phase (*p <0.05, **p <0.01, ***p <0.001, 
****p<0.0001, significantly higher locomotor activity compared to CTRL animals; #p<0.05, 
significantly lower within-group locomotor activity compared to Day 1 in SENS animals). 
(B) Stereotypy following injections for each day of the induction phase (**p< 0.01, 
significantly higher stereotypy ratings compared to CTRL animals; #p<0.05, ##p<0.01, 
significantly higher within-group stereotypy compared to Day 1 in SENS animals). (D) 
Mean interaction time 30 days after the last SAL or 5.0 mg/kg MA injection. All data are 
depicted as mean ± SEM. (MA: n = 10; SAL: n = 10; Partners: n = 7).
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